Organ and Tissue Authority staff during DonateLife Week requires collaboration and cooperation with I am confident that the OTA is well positioned many stakeholders. to transition to new arrangements and we look forward to the Board’s strategic direction I feel very privileged to have been provided the and leadership ensuring continued growth in opportunity to work in this sector. I would like to Australia’s donation and transplantation acknowledge the dedicated and professional outcomes. clinical and technical staff, the DonateLife Network and the OTA staff who continue to embrace change FINANCIAL PERFORMANCE and progress this program to provide life-saving and We have a strong focus on budget management life-changing organ and tissue transplants for and ensuring that resources are appropriately those in need. allocated to optimise our performance. The year ended with a departmental $0.154 million Finally, and most importantly, I acknowledge operating surplus net of unfunded depreciation those who became an organ and/or tissue donor and before the asset revaluation deficit/surplus, during the year, along with their families, without compared to whom transplantation and its life-changing a $0.021 million operating surplus in 2015–16. benefits would not be possible. Administered expenditure for 2016–17 was I am very pleased to present to you the OTA’s $43.765 million towards the delivery of the 2016–17 Annual Report. national reform program. Ms Ann Smith YOU Chief Executive Officer (acting) Optimising potential donation opportunities 30 June 2017
Organ and Tissue Authority staff during DonateLife Week I am confident that the OTA is well positioned to transition to new arrangements and we look forward to the Board’s strategic direction and leadership ensuring continued growth in Australia’s donation and transplantation outcomes. FINANCIAL PERFORMANCE We have a strong focus on budget management and ensuring that resources are appropriately allocated to optimise our performance. The year ended with a departmental $0.154 million operating surplus net of unfunded depreciation and before the asset revaluation deficit/surplus, compared to a $0.021 million operating surplus in 2015–16. Administered expenditure for 2016–17 was $43.765 million towards the delivery of the national reform program. YOU Optimising potential donation opportunities requires collaboration and cooperation with many stakeholders. I feel very privileged to have been provided the opportunity to work in this sector. I would like to acknowledge the dedicated and professional clinical and technical staff, the DonateLife Network and the OTA staff who continue to embrace change and progress this program to provide life-saving and life-changing organ and tissue transplants for those in need. Finally, and most importantly, I acknowledge those who became an organ and/or tissue donor during the year, along with their families, without whom transplantation and its life-changing benefits would not be possible. I am very pleased to present to you the OTA’s 2016–17 Annual Report. Ms Ann Smith Chief Executive Officer (acting) 30 June 2017
OTA%202016-17%20Annual%20Report%20(Parts%201-2).docx